EANO Educational Day - Thursday, October 17, 2024
Note that the programme is subject to change and will be continuously updated.
All times below refer to British Summer Time (BST).
08:30-09:50 hrs
Chairs: tbc
EDB01.1 Dormancy and metastatic recurrence in the brain
tbc
EDB01.2 Tumour-immune crosstalk in brain metastases
Lisa Sevenich, Germany
EDB01.3 Metabolic reprogramming in brain metastases
tbc
EDB01.4 Biology of leptomeningeal metastases
Amanda Fitzpatrick, United Kingdom
Chairs: tbc
EDC01.1 Challenges in developing precision medicine trials for low-grade glioma patients
Mehdi Touat, France
EDC01.2 IDH-inhibitors - how to translate into clinical practice
Marjolein Geurts, Netherlands
EDC01.3 Targeted therapies for circumscribed gliomas
Roberta Ruda, Italy
EDC01.4 Targeted therapy for paediatric low grade gliomas
tbc
Chairs: tbc
EDN01.1 The AHP role in radiotherapy services: improving patient outcomes
Katerina Polachova, Czechia
EDN01.2 Update on radiotherapy modalities
Andrada Turcas, Romania
EDN01.3 Information provision related to radiotherapy treatment and toxicities
Sharon Fernandez, United Kingdom
EDN01.4 Trialing innovation radiation therapy focused educational interventions for patients, carers and health professionals
Georgia Halkett, Australia
09:50-10:00 hrs | BREAK
10:00-11:00 hrs
Chairs: tbc
EDB02.1 Neurons in carcinogenesis inside the CNS
Humsa Venkatesh, United States
EDB02.2 Neurons in carcinogenesis outside the CNS
tbc
EDB02.3 Cancer Neuroscience of brain tumors and beyond: roads to translation
Frank Winkler, Germany
Chairs: tbc
EDC02.1 Primary CNS Lymphoma management in 2024
Jacoline Bromberg, Netherlands
EDC02.2 Multiple metastases
Giuseppe Minniti, Italy
EDC02.3 How I treat Meningioma
Michael Jenkinson, United Kingdom
chair: tbc
EDN02.1 Support needs in paediatric neuro-oncology patients
Kim Bull, United Kingdom
EDN02.2 “Aiming at a moving target” – the daily life challenges of adolescents and young adults (AYA) with a low-grade glioma
Milou Reuvers, Netherlands
EDN02.3 Supporting adolescent and young adult brain tumour patients
Catriona Knowles, United Kingdom
EDN02.4 Panel discussion
all speakers
11:00-11:30 hrs | COFFEE BREAK
11:30-13:00 hrs
chair: tbc
EDB03.1 Analysis of liquid biopsies
tbc
EDB03.2 Liquid biopsies in gliomas
Santiago Cabezas-Camarero , Spain
EDB03.3 Liquid biopsies in metastastic disease
Joan Seoane, Spain
EDB03.4 Liquid biopsy in CNS lymphomas
Andres Ferreri, Italy
Chair: tbc
EDC03.1 Pragmatic trial designs and windows of opportunity
Nader Sanai, United States
EDC03.2 New Bayesian platform trial design
Tobias Kessler, Germany
EDC03.3 Clinical outcome assessment in trials
Johan Koekkoek, Netherlands
EDC03.4 Study design in rare tumours
tbc
Chairs: tbc
EDN03.1 Neuropsychiatric symptoms in brain tumour patients
Martin Klein, Netherlands
EDN03.2 Violence at home
Lisa Kastbom, Sweden
EDN03.3 The challenges of neuropsychiatric symptoms at home
tbc
EDN03.4 Risk assessments and safeguarding
Lena Rosenlund, Sweden
13:00-14:00 hrs | LUNCH BREAK
14:00-15:20 hrs
Chairs: tbc
EDB04.1 Overview of precision medicine approaches - functional vs. omic profiling
Tobias Weiss, Switzerland
EDB04.2 Identification of individualised treatments by molecular profiling
Giuseppe Lombardi, Italy
EDB04.3 tbc
Anna Golebiewska, Luxembourg
EDB04.4 Functional genomic approaches to understand mechanisms of drug response and resistance
Veronica Rendo, Sweden
Chairs: tbc
EDC04.1 Is this a tumour or something else?
Bianka Forgo, Sweden
EDC04.2 Imaging for pre-operative planning
Stephen Price, United Kingdom
EDC04.3 Is this treatment effect or tumour progression - MRI?
Anouk van der Hoorn, Netherlands
EDC04.4 Is this treatment effect or tumour progression - PET?
tbc
Chairs: tbc
EDN04.1 Fear of progression in patients with newly diagnosed brain tumours and their caregivers
Marion Rapp, Germany
EDN04. Patient and caregiver experience of coping with a brain tumour
Anna Zanotto, United States
EDN04.3 Fear of cancer recurrence and death anxiety
Ashlee Loughan, United States
EDN04.4 Coping with fear of recurrence: acceptance and commitment therapy
Christopher Graham, United Kingdom
EDN04.5 Closing remarks
15:20-15:30 hrs | BREAK
15:30-16:30 hrs
Chairs: tbc
EDB05.1 Small molecules
Myra van Linde, Netherlands
EDB05.2 Cellular therapies
tbc
EDB05.3 Devices
Ryan Mathew, United Kingdom
chairs: tbc
Programme tbc
EANO Meeting - Thursday, October 17, 2024
17:00-18:00 hrs
Chairs: tbc
OS01.1 Key points of RANO 2.0 Criteria for High- and Low-Grade Gliomas in Adults: what has changed?
Patrick Wen, United States
OS01.2 PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0)
Nathalie Albert, Germany
OS01.3 RANO resect: achievements and current projects
Philipp Karschnia, Germany
Chairs: tbc
JS01.1 EORTC-2227 (LEGATO): Lomustine with and without reirradiation for first progression of glioblastoma: a randomized phase III study
Tomas Kazda, Czech Republic
JS01.2 EORTC-2334 (LUMEN-1): 177Lu-DOTATATE for recurrent MENingioma: a randomized phase II study
Emiline Tabouret, France
JS01.3 EORTC-2013 (GLIO-RARE): Observational study for assessing treatment and outcome of patients with primary brain tumours diagnosed according to cIMPACT-NOW recommendations and the 2021 WHO classification
Hans-Georg Wirsching, Switzerland
Chairs: tbc
PC01.1 Advanced Molecular Testing - Clinical Con
Anna Berghoff, Austria
PC01.2 Advanced Molecular Testing - Clinical Pro
Ghazaleh Tabatabai, Germany
